Iron: The fifth horseman of the apocalypse?

American Journal of Hematology

Volumn 84, Issue 5, 2009, Pages 263-264

  DeLoughery, Thomas G ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; IRON CHELATE;

ANEMIA; BLOOD TRANSFUSION; CHELATION; ENDOCRINE DISEASE; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HEALTH CARE PERSONNEL; HEART DEATH; HEART FAILURE; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATION; IRON OVERLOAD; IRON STORAGE; LIFESPAN; LIVER TOXICITY; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THALASSEMIA; TREATMENT DURATION;

BLOOD TRANSFUSION; FERRITINS; HEMATOLOGIC DISEASES; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD;

EID: 65649121576     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21413     Document Type: Note

References (20)

1. Maggio A. Light and shadows in the iron chelation treatment of haematological diseases. Br J Haematol 2007;138:407-421. (Pubitemid 47063024)
2. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet 2000;355:2051-2052.
3. Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006;135:574-582.
4. Steensma DP. Myelodysplasia paranoia: Iron as the new radon. Leuk Res, 10.1016/j.leukres.2008.10.017.
5. Chee CE, Steensma DP, Wu W, et al. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. Am J Hematol 2008;83:611-613.
6. Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making. J Clin Oncol 2005;23:7594-7603.
7. Konen E, Ghoti H, Goitein O, et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 2007;82:1013-1016.
8. Fung EB, Harmatz P, Milet M, et al. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol 2007;82:255-265.
9. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: A systematic review of the literature. Am J Med 2004;116 (Suppl 7A):S11-S26.
10. Karam LB, Disco D, Jackson SM, et al. Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levels. Pediatr Blood Cancer 2008;50:62-65.
11. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000;96:76-79.
12. Rose C, Ernst O, Hecquet B, et al. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Haematologica 2007;92:850-853.
13. Lee MH, Means RT Jr. Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance. Am J Med 1995;98:566-571.
14. Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH. The fascinating but deceptive ferritin: To measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol 2006;1 (Suppl 1):S9-S18.
15. Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007;109:4586-4588.
16. Park J, Ohyashiki K, Akata S, et al. Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging. Leuk Res, 10.1016/j.leukres.2008.10.018.
17. Di Tucci AA, Matta G, Deplano S, et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008;93:1385-1388.
18. Chacko J, Pennell DJ, Tanner MA, et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol 2007;138:587-593.
19. Tefferi A, Mesa RA, Pardanani A, et al. Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis - Increased serum ferritin or transfusion load does not. Am J Hematol, 10.1002/ajh.21391.
20. Cervantes F, Dupriez B, Pereira A, et al. A new prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 2009;113:2895-2901